Bioequivalence Study of Didanosine in Children Treated for HIV

NCT00668356 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

26

Enrollment

OTHER

Sponsor class

Stopped questions of the benefit efficacy/risks of ddI during the meal not resolved

Conditions

HIV Infections

Interventions

DRUG: didanosine
DRUG: didanosine

Sponsor

Assistance Publique - Hôpitaux de Paris